Last updated: 9 February 2022 at 5:08pm EST

Michael F. Brigham Net Worth




The estimated Net Worth of Michael F Brigham is at least $1.13 Million dollars as of 28 December 2018. Mr Brigham owns over 47,500 units of Immucell stock worth over $776,010 and over the last 21 years he sold ICCC stock worth over $0. In addition, he makes $354,272 as Pres, CEO, Principal Financial Officer, Treasurer, and Sec. & Director at Immucell.

Mr Brigham ICCC stock SEC Form 4 insiders trading

Mr has made over 12 trades of the Immucell stock since 2005, according to the Form 4 filled with the SEC. Most recently he exercised 47,500 units of ICCC stock worth $80,750 on 28 December 2018.

The largest trade he's ever made was buying 51,000 units of Immucell stock on 27 February 2009 worth over $66,810. On average, Mr trades about 7,056 units every 275 days since 2003. As of 28 December 2018 he still owns at least 204,752 units of Immucell stock.

You can see the complete history of Mr Brigham stock trades at the bottom of the page.





Mr. Michael F. Brigham biography

Michael F. Brigham is the Pres, CEO, Principal Financial Officer, Treasurer, Sec. & Director at Immucell.

What is the salary of Mr Brigham?

As the Pres, CEO, Principal Financial Officer, Treasurer, and Sec. & Director of Immucell, the total compensation of Mr Brigham at Immucell is $354,272. There are no executives at Immucell getting paid more.



How old is Mr Brigham?

Mr Brigham is 60, he's been the Pres, CEO, Principal Financial Officer, Treasurer, and Sec. & Director of Immucell since . There are 6 older and 5 younger executives at Immucell. The oldest executive at Immucell Corp. is Jonathan Rothschild, 66, who is the Independent Director.

What's Mr Brigham's mailing address?

Michael's mailing address filed with the SEC is C/O IMMUCELL CORPORATION, 56 EVERGREEN DRIVE, PORTLAND, ME, 04103.

Insiders trading at Immucell

Over the last 21 years, insiders at Immucell have traded over $168,227 worth of Immucell stock and bought 568,684 units worth $2,330,117 . The most active insiders traders include Jonathan E Rothschild, Norman H Pessin, and Joseph H Crabb. On average, Immucell executives and independent directors trade stock every 50 days with the average trade being worth of $22,979. The most recent stock trade was executed by David Cunningham on 13 June 2022, trading 1,000 units of ICCC stock currently worth $8,000.



What does Immucell do?

immucell corporation is a biotechnology company based out of portland maine. immucell's focus is to create scientifically-proven and practical products that result in a measurable economical impact on animal health and productivity in the dairy and beed industries.



What does Immucell's logo look like?

Immucell Corp. logo

Complete history of Mr Brigham stock trades at Immucell

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
28 Dec 2018 Michael F Brigham
President and CEO
Option 47,500 $1.70 $80,750
28 Dec 2018
204,752
17 Mar 2017 Michael F Brigham
President and CEO
Option 1,000 $5.25 $5,250
17 Mar 2017
157,252
13 Dec 2013 Michael F Brigham
President and CEO
Option 1,000 $3.10 $3,100
13 Dec 2013
156,252
16 Nov 2011 Michael F Brigham
President and CEO
Option 1,000 $3.20 $3,200
16 Nov 2011
155,252
10 Dec 2010 Michael F Brigham
President and CEO
Buy 1,000 $2.00 $2,000
10 Dec 2010
154,870
27 Feb 2009 Michael F Brigham
President and CEO
Buy 51,000 $1.31 $66,810
27 Feb 2009
153,870
2 Jan 2008 Michael F Brigham
President and CEO
Buy 388 $3.27 $1,269
2 Jan 2008
102,870
19 Dec 2007 Michael F Brigham
President and CEO
Buy 612 $3.27 $2,001
19 Dec 2007
102,482
5 Sep 2007 Michael F Brigham
President and CEO
Buy 500 $3.74 $1,870
5 Sep 2007
101,870
28 Mar 2006 Michael F Brigham
President and CEO
Option 12,000 $4.00 $48,000
28 Mar 2006
101,370
7 Dec 2005 Michael F Brigham
President and CEO
Option 500 $1.69 $845
7 Dec 2005
96,276
6 Jun 2005 Michael F Brigham
President and CEO
Option 10,500 $1.94 $20,370
6 Jun 2005
95,776


Immucell executives and stock owners

Immucell executives and other stock owners filed with the SEC include: